When Roche Diabetes Care invited 29 of us who write about diabetes to “Social Media Summit” last week, some of us had the opportunity to visit their factory in Indianapolis that produces Aviva test strips. I toured the factory with Bryan Langford, the director of the product supply team for Roche Diagnostics Operations.

The Accu-Chek Aviva is the only meter and strip combination manufactured in America. Roche makes the Aviva meter in Huntsville, Alabama. Roche built the Indianapolis plant a couple of years before the company launched the Aviva in July 2005.

The other meter that Roche currently markets here is the Accu-Chek Compact Plus. Roche manufactures the test strips for that meter in Germany and manufactures the Accu-Chek Compact Plus meters in Ireland. [Read more →]

The American Medical Association today published the results of a large and long study that is good news for anyone who has diabetes. The study shows that intensive control substantially lowers the risk of some serious complications of diabetes.

No surprise that intensive control works. But the surprise is how well it works.

The study followed 1,375 people with type 1 diabetes for 30 years of their diabetes. The complications measured were proliferative retinopathy, nephropathy, and cardiovascular disease. Conventional treatment led half of them to proliferative retinopathy, one-quarter to nephropathy, and 14 percent to cardiovascular disease.

Those in the intensive therapy group has substantially lower rates of these complications — 21 percent, 9 percent, and 9 percent respectively. Fewer than 1 percent became blind, required kidney replacement, or had an amputation because of diabetes during those 30 years. [Read more →]

Roche Diabetes Care this week took a bold and potentially dangerous step into the unknown. This leading manufacturer of blood glucose meters invited 29 of us who write about diabetes to what they called the “Social Media Summit.” During the past 14 years that I have specialized in writing about diabetes no other diabetes company had ever reached out to us.

When my invitation first arrived, I didn’t recognize the term “social media.” I now understand it to mean bloggers and other patient advocates, like me, who write about diabetes.

On Wednesday and Thursday we met with top company executives at Roche’s North American headquarters in Indianapolis, Indiana. Luc Vierstrate, Roche’s Senior Vice President and General Manager of Roche Diabetes Care North America, kicked off the event over dinner Wednesday. Roche executives turned out in force, probably outnumbering those of us who write about diabetes. At dinner I sat between the medical director and the vice president of sales, each of whom have type 1 diabetes. [Read more →]

Whenever my energy level is inexplicably low as it was on a hike last week, I consume more of the good fats. We get our energy either from carbohydrates or fat.

And now that I eat very few carbs to control my blood glucose level and my weight, I need to get most of my energy from the fat in my diet. But sometimes in my quest to control my weight I don’t get enough of either.

Big mistake.

But what are the good fats? They are those with the highest proportion of monounsaturated fatty acids, explains Dr. Dick Williams. He is a consultant to BalancePoint Health, a cholesterol, weight loss, and diabetes control program headquartered in Boulder, Colorado.

“When you stop burning carbohydrates for energy, you need to turn on your fat burner,” Dr. Williams told us at the most recent meeting of our local diabetes support group. “Some of the best examples of monounsaturated fats are avocados, olive oil, and nuts — especially almonds, pecans, and walnuts.” [Read more →]

The U.S. Food and Drug Administration is finally planning to require that our blood glucose meters will meet high standards of accuracy and precision.

Dr. Margaret Hamburg, the new head of the FDA, recently wrote the American Association of Clinical Endocrinologists, or AACE, that the agency is pressing the International Organization for Standardization, or ISO, to set higher standards of accuracy and precision. “If the ISO standard for accuracy is not revised, the agency…may instead recognize other (higher) performance standards for SMBG [self monitoring blood glucose] devices for management of diabetes,” according to a letter and attachment that she sent to AACE President Dr. Jeffrey Garber, and past presidents Drs. Daniel Duick and Richard Hellman. Dr. Hamburg’s letter was a positive response to a formal request that the AACE made to the FDA in May.

Anyone who has ever tested his or her blood glucose for more than a month or so must be appalled at how inaccurate our blood glucose meters are. In the past ten years or so I must have written a dozen articles pointing out how bad they are.

The FDA didn’t tip its hand yet by putting in writing to the AACE just what new standards it plans to require. But the agency did drop a hint.

About half of the last 31 blood glucose meters that the FDA approved for sale in the U.S. would meet performance standards within 10 mg/dl, when reading should be less than 75 mg/dl, and withing 15 mg/dl, when the reading should be above 75 mg/dl, according to the attachment Dr. Hamburg sent Dr.Garber. The FDA recognizes that when our blood glucose levels are below 75 mg/dl, accuracy becomes even more important.

This morning’s New York Times reported this big news for all of us with diabetes. Even though I subscribe to the print edition, I was out hiking in the Rockies today and haven’t read the paper yet. Thanks to two of my favorite diabetes professionals, Certified Diabetes Educator Karen LaVine and Dr. Richard K. Bernstein, for emailing me the link to that article. This is such good news that I needed to write about it today.

This is a mirror of one of my articles that Health Central published. You can navigate to that site to find my most recent articles.

Walking is the exercise of choice for most people, especially when we would rather be outdoors than in a gym. Walking is one of the best ways to prevent heart disease, the biggest problem that those of us who have diabetes face.

If all we want to do is strengthen our lower body, we need only comfortable clothes and supportive footwear. But walking does little or nothing to strengthen the muscles of our upper body.

Unless we walk with poles, like Ken Mundt does.

“The advantage is that I get a whole upper body workout,” he told me when I called him at his home in Seattle. “My chest muscles get a good workout, because I don’t slam my poles. I place them, and then I push.” [Read more →]

Dental disease is a wake-up call that your diet is harming your body, concludes Dr. Philippe P. Hujoel. He reviewed the two hypotheses about whether or not dental disease is a warning that we are headed toward chronic system illness. After examining all the evidence, he concludes that it is.

“The five-alarm fire bell of a tooth ache is difficult to ignore,” Dr. Hujoel told me. He is professor of dental public health sciences at the University of Washington School of Dentistry in Seattle.

But we do tend to ignore it.

He lays the blame squarely at the feet of Ancel Keys and his believers. Dr. Keys promulgated the lipid hypothesis and focused on excess fat intake as the primary cause of systemic chronic non-communicable diseases — like diabetes. For Dr. Keys a healthy diet consisted of increasing our intake of “fermentable carbohydrates.” [Read more →]

The price of blood glucose meters isn’t the problem. But the price of test strips sure can be.

The last time I looked, some of the leading manufacturers were charging us almost $1 per test strip. For those of us who don’t have health insurance and test a lot, that can get expensive pretty quick.

But now one of the most aggressive manufacturers has introduced a meter that uses even less expensive test strips than its previous best. It also has better specs.

The company is US Diagnostics Inc. in New York, N.Y. They call their new meter the Infinity, which I assume they mean to refer to quality and not price.

You may be able to get the meter at no cost, because meter manufacturers mostly work on the “freebie marketing” model where they give away one of their products to generate a continual market for another, generally disposable, item. A guy named King Gillette pioneered this approach to get us to buy his razor blades. [Read more →]

My new blood glucose meter is perfect for travelling or hiking. It’s small, fast, has a small sample size, and features pre- and post-meal flags. It’s easy to read and has auto coding of test strips. I can even personalize it with a choice of face plates.

At the recent convention of the American Association of Clinical Endocrinologists in Houston I saw this meter at the Arkray USA booth. It impressed me so much that I asked the company to send me one for review.

The Arkray name may not be familiar. But the company says that Arkray USA is the fifth largest blood glucose monitoring company in the world. Arkray USA in Edina, Minnesota, is a wholly owned subsidiary of Arkray Inc. of Kyoto, Japan. Arkray took over Hypoguard USA in 2006 and changed its name to Arkray USA. [Read more →]